Physician profile
Marwa Adi
NPI 1104820190
$2,337.74
in general payments reported to CMS, 2019-2025
18 companies · $268 in 2025
The $268 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $484 · 2020: $66.48 · 2021: $47.84 · 2022: $56.18 · 2023: $661 · 2024: $754 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,683.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $432.92 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Alcon Vision LLC | $414.94 | 2019-2025 | Argos, Clareon, Clareon Panoptix Pro |
| Bausch & Lomb Americas INC. | $213.44 | 2024 | Envista Mx60 Iol, Ic-8 Apthera Iol |
| Biotissue Holdings INC. | $162.81 | 2023-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $134.28 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $124.94 | 2019 | |
| Apellis Pharmaceuticals, INC. | $118.80 | 2023 | Syfovre |
| Allergan, INC. | $116.80 | 2019 | |
| Sun Pharmaceutical Industries INC. | $116.16 | 2025 | |
| Astellas Pharma US INC | $110.93 | 2024 | Izervay |
| Oyster Point Pharma, INC. | $95.24 | 2023 | Tyrvaya |
| Carl Zeiss Meditec USA, INC. | $93.97 | 2023 | Artevo 800 |
| Abbvie INC. | $91.85 | 2023 | Ozurdex |
| Harrow Eye, LLC | $45.73 | 2025 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omeros Corporation | $16.93 | 2021 | |
| Dompe US, INC. | $14.38 | 2021 | |
| Rayner Intraocular Lenses Limited | $14.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marwa Adi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.